<SEC-DOCUMENT>0001104659-25-009895-index.html : 20250206
<SEC-HEADER>0001104659-25-009895.hdr.sgml : 20250206
<ACCEPTANCE-DATETIME>20250206080015
ACCESSION NUMBER:		0001104659-25-009895
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		6
CONFORMED PERIOD OF REPORT:	20250206
FILED AS OF DATE:		20250206
DATE AS OF CHANGE:		20250206

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BELITE BIO, INC
		CENTRAL INDEX KEY:			0001889109
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41359
		FILM NUMBER:		25595506

	BUSINESS ADDRESS:	
		STREET 1:		12750 HIGH BLUFF DRIVE SUITE 475
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130
		BUSINESS PHONE:		858-246-6240

	MAIL ADDRESS:	
		STREET 1:		12750 HIGH BLUFF DRIVE SUITE 475
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>tm255706d1_6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
Document 1 - file: tm255706d1_6k.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>tm255706d1_ex1-1.htm
<DESCRIPTION>EXHIBIT 1.1
<TEXT>
Document 2 - file: tm255706d1_ex1-1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.2
<SEQUENCE>3
<FILENAME>tm255706d1_ex1-2.htm
<DESCRIPTION>EXHIBIT 1.2
<TEXT>
Document 3 - file: tm255706d1_ex1-2.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>4
<FILENAME>tm255706d1_ex4-1.htm
<DESCRIPTION>EZHIBIT 4.1
<TEXT>
Document 4 - file: tm255706d1_ex4-1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>5
<FILENAME>tm255706d1_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
Document 5 - file: tm255706d1_ex99-1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>tm255706d1_ex99-1img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 6 - file: tm255706d1_ex99-1img001.jpg

</DOCUMENT>
</SEC-DOCUMENT>